Sun BioPharma, Inc. Note Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Senior Convertible Promissory Tranche B Note between Panbela Therapeutics, Inc. and Nant Capital, LLC (November 2024)
Note Agreements
Sun BioPharma, Inc.
Biotechnology
DE
2024
Subordinated Promissory Note between Panbela Therapeutics, Inc. and Michael T. Cullen dated August 19, 2024
Note Agreements
Sun BioPharma, Inc.
Biotechnology
MN
2024
Senior Convertible Promissory Tranche A Note between Panbela Therapeutics, Inc. and Nant Capital, LLC (October 22, 2024)
Note Agreements
Sun BioPharma, Inc.
Biotechnology
DE
2024
Note Purchase Agreement between Panbela Therapeutics Inc. and Nant Capital, LLC (October 22, 2024)
Note Agreements
Sun BioPharma, Inc.
Biotechnology
CA
2024
Subordinated Promissory Note between Panbela Therapeutics, Inc. and D. Robert Schemel, dated August 8, 2024
Note Agreements
Sun BioPharma, Inc.
Biotechnology
MN
2024
Term Promissory Note between Panbela Therapeutics, Inc. and USWM, LLC dated July 24, 2024
Note Agreements
Sun BioPharma, Inc.
Biotechnology
KY
2024
Sun BioPharma, Inc. Convertible Promissory Note Agreement with Investor
Note Agreements
Sun BioPharma, Inc.
Biotechnology
DE
2018
Sun BioPharma, Inc. Convertible Promissory Note Agreement (2017)
Note Agreements
Sun BioPharma, Inc.
Biotechnology
DE
2017
Note Purchase Agreement between Sun BioPharma, Inc. and Investors (2017)
Note Agreements
Sun BioPharma, Inc.
Biotechnology
DE
2017
Sun BioPharma, Inc. Convertible Promissory Note Agreement with Holder
Note Agreements
Sun BioPharma, Inc.
Biotechnology
DE
2015